Advanced BioMedical Technologies, Inc. ABMT
OTC PK
| 07/31/2021 | 04/30/2021 | ||||
|---|---|---|---|---|---|
| Revenue | -80.00% | 150.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -80.00% | 150.00% | |||
| Cost of Revenue | -100.00% | 100.00% | |||
| Gross Profit | 0.00% | 200.00% | |||
| SG&A Expenses | -14.36% | -31.15% | |||
| Depreciation & Amortization | -54.79% | -15.65% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.60% | -5.75% | |||
| Operating Income | 3.95% | 5.90% | |||
| Income Before Tax | 3.17% | 9.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.17% | 9.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.17% | 9.82% | |||
| EBIT | 3.95% | 5.90% | |||
| EBITDA | 3.47% | 5.84% | |||
| EPS Basic | 3.45% | 10.00% | |||
| Normalized Basic EPS | 0.00% | 10.53% | |||
| EPS Diluted | 3.45% | 10.00% | |||
| Normalized Diluted EPS | 0.00% | 10.53% | |||
| Average Basic Shares Outstanding | 0.36% | 0.41% | |||
| Average Diluted Shares Outstanding | 0.36% | 0.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||